MedTrace Logo

Find the Adequate Dose of Nalbuphine for Laparoscopic Cholecystectomy

NCT04135534 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2019-10-22

No results posted yet for this study

Summary

This study evaluate the adequate dose of mutonpain for laparoscopic cholecystectomy in the management of post operative pain. The investigators will randomize patients into three groups to compare the analgesia effects and side effects.

Conditions

  • Post Operative Pain
  • Opioid Side Effects

Interventions

DRUG

group A

mutonpain 0.05 mg/kg

DRUG

group B

mutonpain 0.1 mg/kg

DRUG

group C

mutonpain 0.2 mg/kg

Sponsors & Collaborators

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    lead OTHER

Principal Investigators

  • Guan-Yu Chen, MD · Kaohsiung Medical University Chung-Ho Memorial Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2020-11-01
Completion
2020-12-01

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04135534 on ClinicalTrials.gov